0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Environmental Sources Gut & Microbiome Human Health Effects Policy & Risk Sign in to save

Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action

Frontiers in Endocrinology 2021 57 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 55 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Nicole Mohajer, Nicole Mohajer, Chrislyn Y. Du, Christian Checkcinco, Bruce Blumberg

Summary

Researchers reviewed the science behind obesogens, a class of endocrine-disrupting chemicals that promote fat storage and metabolic dysfunction. These compounds act through multiple pathways including disrupting adipose tissue function, altering gut microbiome composition, and interfering with hormonal signaling, with effects that can persist across generations. The review highlights the need for improved chemical screening methods to identify obesogenic substances and protect public health.

Body Systems
Study Type In vivo

Adult and childhood obesity have reached pandemic level proportions. The idea that caloric excess and insufficient levels of physical activity leads to obesity is a commonly accepted answer for unwanted weight gain. This paradigm offers an inconclusive explanation as the world continually moves towards an unhealthier and heavier existence irrespective of energy balance. Endocrine disrupting chemicals (EDCs) are chemicals that resemble natural hormones and disrupt endocrine function by interfering with the body's endogenous hormones. A subset of EDCs called obesogens have been found to cause metabolic disruptions such as increased fat storage, in vivo. Obesogens act on the metabolic system through multiple avenues and have been found to affect the homeostasis of a variety of systems such as the gut microbiome and adipose tissue functioning. Obesogenic compounds have been shown to cause metabolic disturbances later in life that can even pass into multiple future generations, post exposure. The rising rates of obesity and related metabolic disease are demanding increasing attention on chemical screening efforts and worldwide preventative strategies to keep the public and future generations safe. This review addresses the most current findings on known obesogens and their effects on the metabolic system, the mechanisms of action through which they act upon, and the screening efforts through which they were identified with. The interplay between obesogens, brown adipose tissue, and the gut microbiome are major topics that will be covered.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Per- and Polyfluoroalkyl Substances (PFAS) as Emerging Obesogens: Mechanisms, Epidemiological Evidence, and Regulatory Challenges

This review examines growing evidence that PFAS, the 'forever chemicals' found in many consumer products, may act as obesogens, meaning they could promote obesity by disrupting hormones and fat metabolism. PFAS exposure has been linked to changes in how the body stores fat and processes lipids, with some studies suggesting maternal exposure may increase obesity risk in children. While focused on PFAS rather than microplastics, the findings are relevant because both are persistent environmental pollutants that can act as endocrine disruptors.

Article Tier 2

A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: Where exposomics meets metabolomics

This review examines how environmental chemicals, including contaminants associated with plastics, can disrupt human metabolism and contribute to conditions like obesity and diabetes. Researchers mapped the connections between chemical exposure and changes in metabolic biomarkers that signal disease risk. The study highlights the emerging field of metabolism-disrupting chemicals and the importance of understanding how everyday environmental exposures influence long-term metabolic health.

Article Tier 2

Are microplastics in food a risk factor for obesity: Current evidence, mechanistic pathways and emerging health risks associated with human exposure

This review examines the emerging evidence linking microplastic and nanoplastic exposure to metabolic dysfunction and potential obesity risk. Researchers found that these particles have been detected in multiple human tissues and may contribute to inflammation, hormonal disruption, gut microbiome changes, and altered fat cell development. While animal and laboratory studies support a plausible connection, the study notes that direct evidence in humans is still limited and further research is needed.

Clinical Trial Tier 1

Endobolome, a New Concept for Determining the Influence of Microbiota Disrupting Chemicals (MDC) in Relation to Specific Endocrine Pathogenesis

This paper introduces the concept of the 'endobolome' to describe gut microbiota genes involved in metabolizing steroid hormones and endocrine disrupting chemicals. The authors propose that dysbiosis can alter hormone metabolism and that certain xenobiotics should be classified as 'microbiota disrupting chemicals' (MDC) based on their ability to promote gut microbial changes linked to chronic disease.

Article Tier 2

Weighty Consequences: Pollution’s Hidden Weight in the Obesity Epidemic: A Narrative Review

This narrative review examines evidence linking environmental pollutants—including air pollution, persistent organic pollutants, and microplastics—to obesity and metabolic disruption. It highlights biological mechanisms by which pollutants act as obesogens and calls for pollution to be considered a driver of the global obesity epidemic.

Share this paper